23andMe is cashing in on drugs it developed with your DNA. Should its customers get a cut? Kit Daniels Posted on January 14, 2020 Posted in Aggregated No Comments Tagged with health Vague promises of gene therapies to come were part of the mystique of 23andMe Share this:ShareFacebookRedditTwitterLinkedInEmail
Leave a Reply